Knowing which countries to submit clinical trial results summaries to is the easy part. What becomes difficult is learning the intricacies and transparency requirements of every clinical trial registry globally, including the Clinical Trial Registry of Singapore. Here is an overview of this registry:
Registry name: Clinical Trial Register of Singapore
Year established: 2012
Points of interest:
- Singapore’s Health Science Authority (HSA) oversees the clinical trial register. Founded in 2001, the HAS’s vision is to be the leading innovative authority protecting and advancing national health and safety.
- The main goal of launching the Clinical Trial Register is to increase transparency and accountability to promote better health outcomes. The register helps solve publication bias issues, assists researchers in conducting meta-analyses, and identifies future research opportunities.
- Key data sets in the Clinical Trial Register include: Protocol title/No.; Phase; Therapeutic area; Intervention; Sponsor; Trial site; Principal investigator, and; Status
- In the future, the HSA wants to revamp the register’s IT system, thereby meeting all 20 fields in WHO’s minimal data set.
- The status of trials in the Clinical Trial Register must be updated at least once every six months.
- At the moment, this registry only lists active clinical trial sites in its database and results posting is not a requirement.
Related transparency research/articles:
- Analysis of the Singapore Clinical Laboratories Market 2018 – Forecast to 2021 – ResearchAndMarkets.com
- PowerPoint presentation from Director Foo Yang Tong
- Clinical trial registries: more international, converging efforts are needed
TrialAssure® Registry can automate the disclosure of clinical trial results for the Clinical Trial Registry of Singapore. For questions or a free demo, email email@example.com